Turning cells to sales

October 31, 2006

A number of companies developing stem cell-based therapies believe it’s wise not to keep all of their oocytes in one basket.

Balancing the need to satisfy investors now while funding long-term research and development, stem cell companies are discovering ways to generate revenue sooner rather than later. (MSNBC)